Skip To Content
Free consultation Text or call 312.553.4900

News & Perspective

April 14, 2020

What Should I Do If I Took Zantac? How to Make a Claim Against Drug Manufacturers

In early April, the U.S. Food and Drug Administration (FDA) requested drug manufacturers remove Zantac (and its generic ranitidine equivalents) from the market after an ongoing investigation revealed harmful impurities in the heartburn medication. Ranitidine, the active ingredient in Zantac,...

Read More
March 31, 2020

News to Know: Boy Scouts Bankruptcy, Pharmacy Errors Lead to Complications, and the Dangers of Prescription Overlap

At Hurley McKenna & Mertz, it’s our team’s priority to be up to date on noteworthy news to best serve our clients. Once a month, we round up a list of articles that impact our practice areas, including but not...

Read More
February 29, 2016

Undisclosed Drug Shortages Compromising Patient Safety

If two people you knew were in a life or death situation and you could only save one, who would you choose? This is the decision that doctors, surgeons, and anesthesiologists are making each and every day, but it is...

Read More
August 14, 2015

Bayer Agrees to $56.9 Million Settlement Over Yaz, Yasmin Arterial Blood Clot Claims

According to plaintiffs in the case against Bayer, the makers of the drospierenone-containing Yaz and Yasmin, and Barr Laboratories makers of the generic form, Ocella, the drugs have caused arterial clots that resulted in life-threatening complications, including stroke and heart...

Read More
April 30, 2015

Zofran Use May Be Linked to Birth Defects

Parents want their infants and children to be healthy and thrive. It can be a devastating blow when they find out their child may or will have a life-long condition that may be life-threatening. Congenital heart defects are heart problems...

Read More

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.